1015787-98-0 | Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-

Packsize	Purity	Availability	Price	Discounted Price
1mg	99%	in stock	$36.00	$25.00
5mg	99%	in stock	$67.00	$47.00
10mg	99%	in stock	$105.00	$74.00
100mg	99%	in stock	$470.00	$329.00
250mg	99%	in stock	$736.00	$515.00
1g	99%	in stock	$957.00	$670.00

Description

• Catalog Number: AA06077
• Chemical Name: Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-
• CAS Number: 1015787-98-0
• Molecular Formula: C14H19N5O4S
• Molecular Weight: 353.3968
• MDL Number: MFCD24539325
• SMILES: COc1cc(C(C)C)c(cc1S(=O)(=O)N)Oc1cnc(nc1N)N

Upstream Synthesis Route

Gefapixant, a novel drug compound, has found its niche in the realm of chemical synthesis, showing promise in several key applications. As a potent and selective P2X3 receptor antagonist, Gefapixant's role in chemical synthesis lies in its ability to inhibit and modulate purinergic signaling pathways, offering a unique approach to manipulating biological responses.In the realm of medicinal chemistry, Gefapixant's use as a P2X3 receptor antagonist presents opportunities for designing new drug molecules with enhanced therapeutic efficacy. By targeting specific purinergic receptors, researchers can fine-tune the activity of pharmaceutical compounds to achieve desired pharmacological effects.Furthermore, Gefapixant's involvement in chemical synthesis extends to its potential as a tool compound for studying purinergic signaling mechanisms. Through carefully designed experiments, chemists can leverage Gefapixant's pharmacological properties to probe the intricate pathways associated with P2X3 receptors, revealing valuable insights into their function and potential therapeutic implications.Overall, Gefapixant's application in chemical synthesis represents a pioneering advancement in the field of drug discovery and development, offering researchers a powerful tool to explore the complex interplay between purinergic signaling and biological responses.